Related Experiment Video
Updated: Aug 9, 2026

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome
Published on: March 2, 2018
Chemosensitization effects of XIAP downregulation in K562 leukemia cells
R T Lima1, L M Martins, J E Guimarães
1IPATIMUP, Institute of Molecular Pathology and Immunology of the University of Porto, Portugal.
Abstract:
The effect of downregulation of the expression of the antiapoptotic protein XIAP with antisense oligonucleotides was evaluated in the K562 chronic myeloid leukemia (CML) cell line. This was carried out by studying the effects of downregulation of XIAP expression on cellular viability, cellular apoptosis and on the response to two chemotherapeutical drugs, etoposide and doxorubicin. We document that downregulation of XIAP expression decreased cellular viability, increased cellular apoptosis and enhanced the effects of doxorubicin.
Insights
Downregulating the anti-apoptotic protein XIAP in chronic myeloid leukemia cells reduced viability and increased apoptosis. This also enhanced chemotherapy drug effectiveness.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- Chronic myeloid leukemia (CML) is a hematological malignancy.
- The X-linked inhibitor of apoptosis protein (XIAP) is a key regulator of cell death.
- Targeting XIAP is a potential therapeutic strategy in CML.
Purpose of the Study:
- To investigate the impact of XIAP downregulation on K562 CML cells.
- To assess the effects on cellular viability and apoptosis.
- To determine the influence on response to etoposide and doxorubicin.
Main Methods:
- Utilized antisense oligonucleotides to downregulate XIAP expression in K562 cells.
- Monitored cellular viability and apoptosis levels.
- Evaluated the combined effects with etoposide and doxorubicin treatments.
Main Results:
- Downregulation of XIAP significantly decreased cellular viability.
- XIAP inhibition led to a notable increase in cellular apoptosis.
- Combined treatment with doxorubicin showed enhanced therapeutic effects.
Conclusions:
- XIAP downregulation is a viable strategy to induce apoptosis in CML cells.
- Targeting XIAP can sensitize CML cells to chemotherapy drugs like doxorubicin.
- This approach holds promise for novel CML treatment strategies.
